Published by
@ShahidNShah
@ShahidNShah
Mendaera raises $73M to develop handheld robotics platform
- Mendaera raised $73 million to advance a handheld robotics platform for procedures such as biopsies, organ and vascular access, and pain management, the company said Thursday.
- The Silicon Valley-based firm said it is targeting a new category of robotics focused on common procedures that are involved in many patients’ treatment.
- Mendaera was co-founded by two former employees of Auris Health, the robotics company that Johnson & Johnson acquired for an initial $3.4 billion. Fred Moll, the founder of Intuitive Surgical and Auris, and venture capital funds that invested in Auris participated in Mendaera’s financing.
Continue reading at medtechdive.com
Make faster decisions with community advice
- The Future of 3D Printing Drugs In Pharmacies Is Closer Than You Think
- The Importance of Personalized Care in Your Injury Recovery Journey
- Advancing Aging: The Impact of Technological Innovation and Medical Breakthroughs
- Body Contouring Machine for the Post-Bariatric Surgery Patient: Enhancing Recovery and Aesthetic Results
- CIOs must understand change management theories, frameworks and practices
Next Article
-
The Future of 3D Printing Drugs In Pharmacies Is Closer Than You Think
3D printing drugs is not a fantasy anymore. Unbelievable shapes and any kind of drug can be fabricated with groundbreaking technology. The UK biotech company, FabRx believes it could even appear as a …
Posted Oct 1, 2024 3D Printing Insight & Analysis
